Vimarsana
Biggest News Aggregation in the World

Wolfgang Dummer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wolfgang Dummer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wolfgang Dummer Today - Breaking & Trending Today

Alpine Immune Sciences Announces Appointment of Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer and Grant under Nasdaq Listing Rule 5635(c) - Vimarsana News

Alpine Immune Sciences Announces Appointment of Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer and Grant under Nasdaq Listing Rule 5635(c)

SEATTLE--(BUSINESS WIRE)--Oct 4, 2023--

Rigel Doses First Patient in Phase 1b Study of R289 for the Treatment of Lower-Risk Myelodysplastic Syndromes - Vimarsana News

Rigel Doses First Patient in Phase 1b Study of R289 for the Treatment of Lower-Risk Myelodysplastic Syndromes

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced it dosed the first patient in its Phase 1b study of R289, an IRAK1/4 dual inhibitor,...

Rigel Announces Publication of Early Clinical Data of Olutasidenib in The Lancet Haematology - Vimarsana News

Rigel Announces Publication of Early Clinical Data of Olutasidenib in The Lancet Haematology

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the publication of data in The Lancet Haematology, which summarizes the Phase 1...

Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q2 2022 Results - Earnings Call Transcript - Vimarsana News

Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q2 2022 Results - Earnings Call Transcript

Rigel Pharmaceuticals, Inc. (NASDAQ:NASDAQ:RIGL) Q2 2022 Earnings Conference Call August 02, 2022, 04:30 PM ET Company Participants Dolly Vance - Executive Vice President, Corporate Affairs...

Rigel Pharmaceuticals Provides Business Update - Vimarsana News

Rigel Pharmaceuticals Provides Business Update

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today provided a business update including preliminary 2021 full-year total revenue, the status of...